Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]

Participation in clinical trials

Richard Stephens – VNCRI and NCRN Consumer Liaison Groups

Participation in clinical trials ( Richard Stephens – VNCRI and NCRN Consumer Liaison Groups )

Patient involvement in improvements in standard of care

Tom Haswell - VNCRI and NCRN Consumer Liaison Groups

Patient involvement in improvements in standard of care ( Tom Haswell - VNCRI and NCRN Consumer Liaison Groups )

Benefits of participating in clinical trials and patient liaison groups

Shirley Harrison - VNCRI and NCRN Consumer Liaison Groups

Benefits of participating in clinical trials and patient liaison groups ( Shirley Harrison - VNCRI and NCRN Consumer Liaison Groups )

Treatment of antiphospholipid syndrome with aspirin

Prof Graham Hughes – St Thomas Hospital, London, UK

Treatment of antiphospholipid syndrome with aspirin ( Prof Graham Hughes – St Thomas Hospital, London, UK )

The Helico Eradication Aspirin Trial (HEAT)

Prof Chris Hawkey – The University of Nottingham, UK

The Helico Eradication Aspirin Trial (HEAT) ( Prof Chris Hawkey – The University of Nottingham, UK )

Highlights of the 2012 Aspirin Foundation meeting

Nick Henderson – Executive Director, Aspirin Foundation

Highlights of the 2012 Aspirin Foundation meeting ( Nick Henderson – Executive Director, Aspirin Foundation )

Effects of aspirin on the progression of cancer

Prof Peter Rothwell – Oxford University, UK

Effects of aspirin on the progression of cancer ( Prof Peter Rothwell – Oxford University, UK )

Recent evidence to support the use of aspirin in the treatment of cancer

Dr Ruth Langley – Medical Research Council, London, UK

Recent evidence to support the use of aspirin in the treatment of cancer ( Dr Ruth Langley – Medical Research Council, London, UK )

Effectiveness of PARP inhibitors in ovarian cancer

Prof Jonathan Ledermann - University College London, UK

Effectiveness of PARP inhibitors in ovarian cancer ( Prof Jonathan Ledermann - University College London, UK )

Radical hysterectomy of cervical cancer

Dr Shingo Fujii – Kitano Hospital, Osaka, Japan

Radical hysterectomy of cervical cancer ( Dr Shingo Fujii – Kitano Hospital, Osaka, Japan )

Retrospective study on adjuvant therapy in vulva cancer

Prof Sven Mahner - University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Retrospective study on adjuvant therapy in vulva cancer ( Prof Sven Mahner - University Medical Center Hamburg-Eppendorf, Hamburg, Germany )

Phase III HECTOR study: recurring platinum sensitive ovarian cancer

Prof Sven Mahner - University Medical Center Hamburg-Eppendorf , Hamburg...

Phase III HECTOR study: recurring platinum sensitive ovarian cancer ( Prof Sven Mahner - University Medical Center Hamburg-Eppendorf , Hamburg, Germany )

More from ecancer